IBDEI1ET ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25274,0)
 ;;=782.1^^145^1537^65
 ;;^UTILITY(U,$J,358.3,25274,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25274,1,4,0)
 ;;=4^782.1
 ;;^UTILITY(U,$J,358.3,25274,1,5,0)
 ;;=5^Rash NOS
 ;;^UTILITY(U,$J,358.3,25274,2)
 ;;=^102948
 ;;^UTILITY(U,$J,358.3,25275,0)
 ;;=706.2^^145^1537^69
 ;;^UTILITY(U,$J,358.3,25275,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25275,1,4,0)
 ;;=4^706.2
 ;;^UTILITY(U,$J,358.3,25275,1,5,0)
 ;;=5^Sebaceous Cyst
 ;;^UTILITY(U,$J,358.3,25275,2)
 ;;=^41304
 ;;^UTILITY(U,$J,358.3,25276,0)
 ;;=690.10^^145^1537^72
 ;;^UTILITY(U,$J,358.3,25276,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25276,1,4,0)
 ;;=4^690.10
 ;;^UTILITY(U,$J,358.3,25276,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,25276,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,25277,0)
 ;;=702.11^^145^1537^70
 ;;^UTILITY(U,$J,358.3,25277,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25277,1,4,0)
 ;;=4^702.11
 ;;^UTILITY(U,$J,358.3,25277,1,5,0)
 ;;=5^Seborrh Keratosis, Inflammatory
 ;;^UTILITY(U,$J,358.3,25277,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,25278,0)
 ;;=702.19^^145^1537^71
 ;;^UTILITY(U,$J,358.3,25278,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25278,1,4,0)
 ;;=4^702.19
 ;;^UTILITY(U,$J,358.3,25278,1,5,0)
 ;;=5^Seborrh Keratosis, Other
 ;;^UTILITY(U,$J,358.3,25278,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,25279,0)
 ;;=686.9^^145^1537^73
 ;;^UTILITY(U,$J,358.3,25279,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25279,1,4,0)
 ;;=4^686.9
 ;;^UTILITY(U,$J,358.3,25279,1,5,0)
 ;;=5^Skin Infec, Local Unsp
 ;;^UTILITY(U,$J,358.3,25279,2)
 ;;=^123943
 ;;^UTILITY(U,$J,358.3,25280,0)
 ;;=708.9^^145^1537^86
 ;;^UTILITY(U,$J,358.3,25280,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25280,1,4,0)
 ;;=4^708.9
 ;;^UTILITY(U,$J,358.3,25280,1,5,0)
 ;;=5^Urticaria, Unsp
 ;;^UTILITY(U,$J,358.3,25280,2)
 ;;=^124650
 ;;^UTILITY(U,$J,358.3,25281,0)
 ;;=078.10^^145^1537^87
 ;;^UTILITY(U,$J,358.3,25281,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25281,1,4,0)
 ;;=4^078.10
 ;;^UTILITY(U,$J,358.3,25281,1,5,0)
 ;;=5^Warts
 ;;^UTILITY(U,$J,358.3,25281,2)
 ;;=^295787
 ;;^UTILITY(U,$J,358.3,25282,0)
 ;;=706.8^^145^1537^88
 ;;^UTILITY(U,$J,358.3,25282,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25282,1,4,0)
 ;;=4^706.8
 ;;^UTILITY(U,$J,358.3,25282,1,5,0)
 ;;=5^Xerosis
 ;;^UTILITY(U,$J,358.3,25282,2)
 ;;=^271931
 ;;^UTILITY(U,$J,358.3,25283,0)
 ;;=710.1^^145^1537^68
 ;;^UTILITY(U,$J,358.3,25283,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25283,1,4,0)
 ;;=4^710.1
 ;;^UTILITY(U,$J,358.3,25283,1,5,0)
 ;;=5^Scleroderma
 ;;^UTILITY(U,$J,358.3,25283,2)
 ;;=Scleroderma^108590
 ;;^UTILITY(U,$J,358.3,25284,0)
 ;;=707.21^^145^1537^54
 ;;^UTILITY(U,$J,358.3,25284,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25284,1,4,0)
 ;;=4^707.21
 ;;^UTILITY(U,$J,358.3,25284,1,5,0)
 ;;=5^Pressure Ulcer,Stage I
 ;;^UTILITY(U,$J,358.3,25284,2)
 ;;=^336649
 ;;^UTILITY(U,$J,358.3,25285,0)
 ;;=707.22^^145^1537^55
 ;;^UTILITY(U,$J,358.3,25285,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25285,1,4,0)
 ;;=4^707.22
 ;;^UTILITY(U,$J,358.3,25285,1,5,0)
 ;;=5^Pressure Ulcer,Stage II
 ;;^UTILITY(U,$J,358.3,25285,2)
 ;;=^336650
 ;;^UTILITY(U,$J,358.3,25286,0)
 ;;=707.23^^145^1537^56
 ;;^UTILITY(U,$J,358.3,25286,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25286,1,4,0)
 ;;=4^707.23
 ;;^UTILITY(U,$J,358.3,25286,1,5,0)
 ;;=5^Pressure Ulcer,Stage III
 ;;^UTILITY(U,$J,358.3,25286,2)
 ;;=^336651
 ;;^UTILITY(U,$J,358.3,25287,0)
 ;;=707.24^^145^1537^57
 ;;^UTILITY(U,$J,358.3,25287,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25287,1,4,0)
 ;;=4^707.24
 ;;^UTILITY(U,$J,358.3,25287,1,5,0)
 ;;=5^Pressure Ulcer,Stage IV
